Washington Trust CO Edwards Lifesciences Corp Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Washington Trust CO holds 575 shares of EW stock, worth $42,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares

575

Previous 757 24.04%

Holding current value

$42,619

Previous $69,000 46.38%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$59.7 - $93.78 $10,865 - $17,067	-182 Reduced 24.04%	575 $37,000
Q2 2024 Jul 15, 2024	BUY	$84.3 - $94.31 $1,517 - $1,697	18 Added 2.44%	757 $69,000
Q1 2024 Apr 23, 2024	BUY	$72.54 - $95.56 $797 - $1,051	11 Added 1.51%	739 $70,000
Q4 2023 Jan 18, 2024	SELL	$61.71 - $77.76 $123 - $155	-2 Reduced 0.27%	728 $55,000
Q2 2023 Jul 27, 2023	BUY	$81.41 - $94.33 $2,605 - $3,018	32 Added 4.58%	730 $68,000
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $52,204 - $59,410	703 Added 70300.0%	704 $58,000
Q1 2023 May 04, 2023	SELL	$74.26 - $84.51 $51,759 - $58,903	-697 Reduced 99.86%	1 $57,000
Q4 2022 Jul 27, 2023	SELL	$68.3 - $87.44 $409 - $524	-6 Reduced 0.85%	698 $52,000
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $34,150 - $43,720	500 Added 252.53%	698 $52,000
Q3 2022 Oct 14, 2022	SELL	$82.37 - $107.29 $2,718 - $3,540	-33 Reduced 14.29%	198 $16,000
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $22,836 - $33,863	-264 Reduced 53.33%	231 $22,000
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $305 - $385	-3 Reduced 0.6%	495 $59,000
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $7.23 Million - $8.88 Million	-67,966 Reduced 99.27%	498 $64,000
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $2,675 - $3,191	26 Added 0.04%	68,464 $7.75 Million
Q2 2021 Aug 05, 2021	BUY	$83.84 - $104.76 $22,385 - $27,970	267 Added 0.39%	68,438 $7.09 Million
Q1 2021 Apr 28, 2021	SELL	$78.68 - $90.67 $3,147 - $3,626	-40 Reduced 0.06%	68,171 $5.7 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $166,392 - $211,744	2,321 Added 3.52%	68,211 $6.22 Million
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $19,350 - $25,182	-288 Reduced 0.44%	65,890 $5.26 Million
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $2.55 Million - $3.41 Million	44,337 Added 203.0%	66,178 $4.57 Million
Q1 2020 May 07, 2020	BUY	$52.41 - $81.0 $301,829 - $466,479	5,759 Added 35.81%	21,841 $4.12 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $1.15 Million - $1.32 Million	16,082 New	16,082 $3.75 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $28,516 - $36,210	-624 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $26,488 - $32,011	624 New	624 $91,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Edwards Lifesciences Corp Transaction History